Overview

Fluorescence Targeted Pelvic Lymph Node Mapping

Status:
Terminated
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the lymphatic drainage of rectal tumours by using ICG as a fluorescent non-specific marker. As a feasibility study, it will also assess its technique and timing along with its ability to assist in removing lymph nodes when it is clinically indicated.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Oxford University Hospitals NHS Trust